Labeler
Cordavis Limited NDC Codes
Cordavis Limited lists 18 finished drug products in the FDA NDC Directory under NDC labeler code 83457.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Hyrimoz, Humira, Adalimumab-bwwd, Pyzchiva, Ospomyv
- Active ingredients
- Adalimumab, Ustekinumab, Denosumab
- NDC labeler codes
- 83457
- Strengths
- Adalimumab 40 mg/.4mL; Adalimumab 80 mg/.8mL; Adalimumab 40 mg/.8mL; Denosumab 60 mg/mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Adalimumab 20 mg/.2mL
- Dosage forms
- Injection, Solution, Kit, Solution
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Tumor Necrosis Factor Blocker, Interleukin-12 Antagonist, Interleukin-23 Antagonist, RANK Ligand Inhibitor
- HCPCS / J-code
- J0135 — Injection, adalimumab, 20 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 20
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | 83457-186 | 83457-0186-01 | J0135 |
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | 83457-187 | 83457-0187-01 | J0135 |
| Ospomyvdenosumab | Denosumab 60 mg/mL | Injection, SolutionSubcutaneous | 83457-012 | 83457-0012-10 | J0897 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 83457-651 | 83457-0651-0183457-0651-96 | J3357 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 83457-652 | 83457-0652-0183457-0652-96 | J3357 |
| Humiraadalimumab | — | Kit | 83457-124 | 83457-0124-02 | — |
| Humiraadalimumab | — | Kit | 83457-243 | 83457-0243-02 | — |
| Humiraadalimumab | — | Kit | 83457-554 | 83457-0554-02 | — |
| Humiraadalimumab | — | Kit | 83457-616 | 83457-0616-02 | — |
| Humiraadalimumab | — | Kit | 83457-817 | 83457-0817-02 | — |
| Hyrimozadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | 83457-107 | 83457-0107-01 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 20 mg/.2mL | Injection, SolutionSubcutaneous | 83457-108 | 83457-0108-01 | J0135 |
| Hyrimozadalimumab-adaz | — | Kit | 83457-112 | 83457-0112-01 | — |
| Hyrimozadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | 83457-113 | 83457-0113-01 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | 83457-100 | 83457-0100-01 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | 83457-101 | 83457-0101-01 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | 83457-102 | 83457-0102-01 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | 83457-103 | 83457-0103-01 | J0135 |
Cordavis Limited: common questions
- What is Cordavis Limited's NDC labeler code?
- 83457. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cordavis Limited?
- Med-Code's HCPCS directory matches J0135, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.